🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 1 día
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/1994 44,92 48,66 43,04 48,66 +4,00% 12,50% 8.068
03/03/1994 46,79 46,79 43,04 46,79 +0,00% 8,00% 3.767
02/03/1994 43,98 46,79 43,98 46,79 +0,00% 6,38% 11.007
01/03/1994 46,79 46,79 46,79 46,79 +2,04% 0,00% 27
28/02/1994 43,98 45,85 43,98 45,85 +4,26% 4,26% 935
25/02/1994 43,98 43,98 43,98 43,98 -1,05% 0,00% 802
24/02/1994 45,85 45,85 43,98 44,45 -1,04% 4,08% 4.569
23/02/1994 47,72 47,72 43,98 44,92 -4,00% 7,84% 2.351
22/02/1994 46,79 48,66 45,85 46,79 -1,96% 6,00% 1.229
18/02/1994 49,59 49,59 47,72 47,72 -3,77% 3,77% 588
17/02/1994 46,79 49,59 46,79 49,59 +6,00% 6,00% 4.034
16/02/1994 46,79 46,79 46,79 46,79 -3,85% 0,00% 267
15/02/1994 47,72 48,66 46,79 48,66 +4,00% 3,92% 1.202
14/02/1994 46,79 48,66 46,79 46,79 -3,85% 4,00% 1.309
11/02/1994 46,79 48,66 46,79 48,66 +4,00% 4,00% 588
10/02/1994 46,79 48,66 46,79 46,79 +0,00% 4,00% 1.924
09/02/1994 44,92 47,72 44,92 46,79 +2,04% 6,25% 1.897
08/02/1994 47,72 47,72 45,38 45,85 -3,92% 4,90% 1.763
07/02/1994 44,92 47,72 43,04 47,72 +2,00% 10,42% 5.370
04/02/1994 48,66 48,66 46,79 46,79 -9,09% 3,85% 5.530
03/02/1994 48,66 51,47 48,66 51,47 +0,00% 5,77% 2.378
02/02/1994 46,79 51,47 46,79 51,47 +5,77% 10,00% 5.156
01/02/1994 48,66 50,53 47,72 48,66 +4,00% 5,77% 1.737
31/01/1994 50,53 50,53 46,79 46,79 -5,66% 7,41% 641
28/01/1994 47,72 49,59 45,85 49,59 +3,92% 7,84% 11.702
27/01/1994 46,79 47,72 45,85 47,72 +4,08% 4,00% 5.771
26/01/1994 47,72 47,72 45,85 45,85 -3,92% 3,92% 882
25/01/1994 47,26 47,72 45,85 47,72 +2,00% 3,96% 1.550
24/01/1994 45,85 47,72 45,85 46,79 +2,04% 4,08% 2.111
21/01/1994 46,79 47,72 45,85 45,85 -2,00% 4,00% 8.362